SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-24-018546
Filing Date
2024-04-26
Accepted
2024-04-26 14:31:26
Documents
20
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A aadi-20240426.htm   iXBRL DEF 14A 637057
6 aadi-20240426_g1.jpg GRAPHIC 2935
7 aadi-20240426_g2.jpg GRAPHIC 123481
8 aadi-20240426_g3.jpg GRAPHIC 126843
9 aadi-20240426_g4.jpg GRAPHIC 467300
10 aadi-20240426_g5.jpg GRAPHIC 255306
  Complete submission text file 0001628280-24-018546.txt   3601411

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20240426.xsd EX-101.SCH 3181
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aadi-20240426_def.xml EX-101.DEF 5963
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20240426_lab.xml EX-101.LAB 4422
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20240426_pre.xml EX-101.PRE 4512
23 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20240426_htm.xml XML 141246
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38560 | Film No.: 24882211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)